Cboe Global Markets
CBOECboe USUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $364.81 Prior regular-session close from the quote source.
- $359.96–$371.06 Regular-session low and high so far today.
- 1.2M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 5 projected Projected for 2027-02-05 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $227.15–$371.18 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own CBOE if Cboe monetizes structural, fee-bearing market infrastructure (options, equities, clearing, market data) whose high fixed-cost platform and regulatory moat convert rising volumes and data licensing into durable cash flow and EPS growth, provided market-data pricing.
CBOE price history
Loading recent earnings…
Investment thesis
What must happen next
Cboe’s core fee-bearing products (options transaction fees, exchange-listed ETP/equities fees and proprietary market-data licensing) are sticky and scale with market activity, producing durable revenue growth because customers cannot easily replicate or fully substitute consolidated tape and deep listed-options liquidity.StrengtheningMateriality: High
Revenue increased from $3,773,500,000 (FY 2023) to $4,094,500,000 (FY 2024) and to $4,714,200,000 (FY 2025), showing sustained top-line growth. If true, revenue growth will be resilient to cyclical volume swings and support premium valuation; if false, revenue could fall or be forced to the low-margin peer level.
Watch: Regulatory action that materially reduces exchange market-data/tape pricing or redistributes tape economics (e.g., consolidated-tape reforms by the SEC).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue increased from $3,773,500,000 (FY 2023) to $4,094,500,000 (FY 2024) and to $4,714,200,000 (FY 2025), showing sustained top-line growth.
Open source ↗Cboe’s fixed-cost trading and clearing platform yields operating leverage: rising volumes and higher-value listings/data monetize largely without proportional expense increases, so operating income should grow faster than revenue absent large strategic spending.StrengtheningMateriality: High
Operating income rose from $1,057,900,000 (FY 2023) to $1,098,400,000 (FY 2024) and to $1,467,100,000 (FY 2025). Operating leverage converts revenue gains into outsized operating income and free cash flow, which supports EPS growth and the premium multiple; if leverage fails (higher recurring opex or one-time restructuring costs), margins and cash returns will be weaker.
Watch: Sustained, material increases in recurring operating expenses—for example, if management funds long-term strategic initiatives or integration costs—eroding leverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating income rose from $1,057,900,000 (FY 2023) to $1,098,400,000 (FY 2024) and to $1,467,100,000 (FY 2025).
Open source ↗Cboe converts operating profits into strong operating cash flow, enabling buybacks/dividends and supporting EPS growth — thus cash generation, not accounting EPS alone, underpins shareholder returns.StrengtheningMateriality: Medium
Operating cash flow grew from $1,075,600,000 (FY 2023) to $1,100,600,000 (FY 2024) and to $1,752,600,000 (FY 2025), showing improved cash generation. If operating cash flow remains strong, management has flexibility for buybacks/dividends or disciplined M&A that compound per-share value; if cash conversion weakens, EPS gains may be less durable and the premium multiple at risk.
Watch: Large cash outflows for acquisitions, unsuccessful sale proceeds not realized, or materially higher capex that reduce free cash available for buybacks/dividends.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating cash flow grew from $1,075,600,000 (FY 2023) to $1,100,600,000 (FY 2024) and to $1,752,600,000 (FY 2025), showing improved cash.
Open source ↗The 2025 strategic review (wind-downs and sales of non-core regional equities/derivatives operations) should raise overall margin and ROIC by removing lower-margin businesses and focusing capital on the options/data/clearing franchise — but only if sales close and cost savings are realized.HoldingMateriality: Medium
Gross profit increased from $1,918,000,000 (FY 2023) to $2,072,400,000 (FY 2024) and to $2,429,100,000 (FY 2025), concurrent with management’s announced wind-downs/sales. Successful portfolio rationalization increases consolidated gross and operating profits and supports the premium valuation; failure to realize proceeds or ongoing losses from these assets will weaken margins and cash flow.
Watch: Sale processes for Cboe Australia/Canada fail to close or close at low prices, leaving the company with the costs and impaired assets.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Gross profit increased from $1,918,000,000 (FY 2023) to $2,072,400,000 (FY 2024) and to $2,429,100,000 (FY 2025), concurrent with management’s announced.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Cboe’s core fee-bearing products (options transaction fees, exchange-listed ETP/equities fees and proprietary market-data licensing) are sticky and scale with market activity, producing durable revenue growth because customers cannot easily replicate or fully substitute consolidated tape and deep listed-options liquidity. If true, revenue growth will be resilient to cyclical volume swings and support premium valuation; if false, revenue could fall or be forced to the low-margin peer level.
Cboe’s fixed-cost trading and clearing platform yields operating leverage: rising volumes and higher-value listings/data monetize largely without proportional expense increases, so operating income should grow faster than revenue absent large strategic spending. Operating leverage converts revenue gains into outsized operating income and free cash flow, which supports EPS growth and the premium multiple; if leverage fails (higher recurring opex or one-time restructuring costs), margins and cash returns will be weaker.
Cboe converts operating profits into strong operating cash flow, enabling buybacks/dividends and supporting EPS growth — thus cash generation, not accounting EPS alone, underpins shareholder returns. If operating cash flow remains strong, management has flexibility for buybacks/dividends or disciplined M&A that compound per-share value; if cash conversion weakens, EPS gains may be less durable and the premium multiple at risk.
The 2025 strategic review (wind-downs and sales of non-core regional equities/derivatives operations) should raise overall margin and ROIC by removing lower-margin businesses and focusing capital on the options/data/clearing franchise — but only if sales close and cost savings are realized. Successful portfolio rationalization increases consolidated gross and operating profits and supports the premium valuation; failure to realize proceeds or ongoing losses from these assets will weaken margins and cash flow.
All standing thesis claims
Original report summary
Cboe monetizes structural, fee-bearing market infrastructure (options, equities, clearing, market data) whose high fixed-cost platform and regulatory moat convert rising volumes and data licensing into durable cash flow and EPS growth, provided market-data pricing.
Bull case and bear case
Bull case and bear case for CBOE Global Markets
Where the evidence on CBOE Global Markets stands: Holding on the latest evidence (Nov 10, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.
Bull case: what the evidence supports
Cboe’s core fee-bearing products (options transaction fees, exchange-listed ETP/equities fees and proprietary market-data licensing) are sticky and scale with market activity, producing durable revenue growth because customers cannot easily replicate or fully substitute consolidated tape and deep listed-options liquidity.
Cboe’s fixed-cost trading and clearing platform yields operating leverage: rising volumes and higher-value listings/data monetize largely without proportional expense increases, so operating income should grow faster than revenue absent large strategic spending.
Cboe converts operating profits into strong operating cash flow, enabling buybacks/dividends and supporting EPS growth — thus cash generation, not accounting EPS alone, underpins shareholder returns.
The 2025 strategic review (wind-downs and sales of non-core regional equities/derivatives operations) should raise overall margin and ROIC by removing lower-margin businesses and focusing capital on the options/data/clearing franchise — but only if sales close and cost savings are realized.
Bear case: what would count against it
Regulatory action that materially reduces exchange market-data/tape pricing or redistributes tape economics (e.g., consolidated-tape reforms by the SEC).
Sustained, material increases in recurring operating expenses—for example, if management funds long-term strategic initiatives or integration costs—eroding leverage.
Large cash outflows for acquisitions, unsuccessful sale proceeds not realized, or materially higher capex that reduce free cash available for buybacks/dividends.
Thesis-Break Engine
What has broken in CBOE Global Markets’s thesis
Each break OptimistFi flagged on CBOE Global Markets, dated — with what has historically followed the same kind of break across the market, not a forecast for CBOE Global Markets.
- Price target fell below the stockcondition set before this filing
Across all companies, this kind of break has happened 1,809 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
CBOE Global Markets filed an SEC 8-K on 2026-10-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
CBOE Global Markets filed an SEC 8-K on 2026-09-29: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
CBOE Global Markets filed an SEC 8-K on 2026-07-31: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Regulatory action that materially reduces exchange market-data/tape pricing or redistributes tape economics (e.g., consolidated-tape reforms by the SEC).
- Sustained, material increases in recurring operating expenses—for example, if management funds long-term strategic initiatives or integration costs—eroding leverage.
- Large cash outflows for acquisitions, unsuccessful sale proceeds not realized, or materially higher capex that reduce free cash available for buybacks/dividends.
- Sale processes for Cboe Australia/Canada fail to close or close at low prices, leaving the company with the costs and impaired assets.
CBOE news
Loading headlines…
Financial statements
CBOE income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
CBOE: quick answers
- When does CBOE Global Markets (CBOE) report earnings next?
- CBOE Global Markets's next results are projected for February 5, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 30, 2026. Earnings calendar
- What is CBOE's short interest?
- As of October 30, 2026, 2.1M CBOE shares were sold short, 2.02% of its shares outstanding, down 29.0% from the count before. At the stock's average daily volume that is 1.6 days to cover. FINRA publishes the count twice a month. CBOE short interest history
- Have members of Congress traded CBOE?
- Reports made public in the last 90 days disclose 2 trades in CBOE by 1 filer: 1 purchase and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed CBOE trade
- Which well-known investors own CBOE?
- 2 of the 37 well-known funds tracked here reported CBOE shares in their latest 13F filings. By share of the fund's portfolio: Markel Group (Tom Gayner), 0.1%; Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios
CBOE in well-known investors’ portfolios
2 of 37 funds reported CBOE shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Tom GaynerMarkel Group | 0.09% | $12.0M | No change | Q3 2026 |
| Ray DalioBridgewater Associates | 0.05% | $12.5M | +246.8% | Q2 2026 |
